Its other two operations, in Italy and Ireland, are expected to receive a combined R1.2bn, with Poland’s Scanmed receiving R77 million.
Group chief executive Dr Shrey Viranna said on Friday that South Africa had good growth prospects, despite experiencing low economic growth. “We are going to use our capital expenditure for maintenance and investments in countries that we operate in. South Africa remains one of our key markets and the challenges that country faces do not stop us from investing. There are challenges in all the regions we operate in and the UK can also be affected by Brexit.
“The group remains committed to its strategy of evolving its business model, such that 35percent of group revenue is now derived from outside the acute hospital business,” Dr Viranna said....
Photo - http://v.duta.us/HA-T4QAA
Click here to read more— - http://v.duta.us/YMooZQAA